BRIEF-Ziopharm and Intrexon announce cooperative research and development agreement with NCI utilizing sleeping beauty system to generate T Cells targeting Neoantigens
January 10, 2017 at 08:49 AM EST
* Ziopharm and Intrexon announce cooperative research and development agreement with the National Cancer Institute utilizing sleeping beauty system to generate T Cells targeting Neoantigens Source text for Eikon: Further company coverage: